Physician profile
Gregory J Omlor
NPI 1861578296
$3,873.92
in general payments reported to CMS, 2019-2025
34 companies · $706 in 2025
The $706 reported for 2025 was more than what 83% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,258 · 2020: $298 · 2021: $511 · 2022: $414 · 2023: $237 · 2024: $450 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $730.52 | 2019-2025 | Trikafta |
| Abbvie INC. | $442.04 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $396.56 | 2019-2025 | Xywav |
| Genentech USA, INC. | $224.38 | 2019-2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $216.91 | 2019-2025 | Fasenra |
| Sobi, INC | $186.33 | 2019-2023 | |
| Electromed, INC. | $144.68 | 2019-2025 | Smartvest |
| Mylan Specialty L.P. | $143.78 | 2022-2024 | Tobi Podhaler |
| Genzyme Corporation | $141.85 | 2019-2024 | |
| Amgen INC. | $141.74 | 2021-2025 | Tezspire |
| Glaxosmithkline, LLC. | $135.85 | 2019-2025 | Nucala |
| Eisai INC. | $125.00 | 2019 | |
| Philips North America LLC | $103.02 | 2020-2025 | Vest Therapy Und |
| Baxter Healthcare | $76.03 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Nestle Healthcare Nutrition INC. | $67.93 | 2021-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $64.79 | 2024-2025 | Lumryz |
| Gilead Sciences, INC. | $63.55 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $61.78 | 2024-2025 | Dupixent |
| Teva Pharmaceuticals USA, INC. | $55.45 | 2021 | |
| Chiesi USA, INC. | $49.87 | 2019-2022 | |
| Harmony Biosciences LLC | $37.27 | 2025 | |
| Digestive Care, INC. | $32.39 | 2024-2025 | Pertzye |
| Azurity Pharmaceuticals, INC. | $32.15 | 2025 | Alvesco |
| Viatris Specialty LLC | $27.16 | 2025 | Tobi Podhaler |
| Vivus LLC | $24.74 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.86 | 2019-2020 | |
| Phadia US INC. | $22.85 | 2024 | Immunocap |
| Resmed Corp | $21.16 | 2025 | |
| Shionogi INC | $18.16 | 2021 | |
| Fisher & Paykel Healthcare INC | $18.10 | 2024 | Fisher & Paykel Healthcare |
| Advanced Respiratory, INC | $17.50 | 2021 | |
| Pari Respiratory Equipment, INC. | $14.36 | 2021 | |
| Aimmune Therapeutics, INC. | $13.16 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Omlor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.